JPMorgan Chase & Co’s Salarius Pharmaceuticals SLRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,000
| Closed | -$1.49K | – | 6641 |
|
|
2023
Q2 | $1.49K | Buy |
+1,000
| New | +$1.49K | ﹤0.01% | 5482 |
|
|
2022
Q2 | – | Sell |
-2,857
| Closed | -$1K | – | 5883 |
|
|
2022
Q1 | $1K | Buy |
+2,857
| New | +$1K | ﹤0.01% | 5660 |
|
|
2020
Q1 | – | Sell |
-13
| Closed | – | – | 4816 |
|
|
2019
Q4 | $0 | Buy |
+13
| New | – | ﹤0.01% | 4858 |
|
|
2019
Q3 | – | Sell |
-342
| Closed | – | – | 4896 |
|
|
2019
Q2 | $0 | Hold |
342
| – | – | ﹤0.01% | 4934 |
|
|
2019
Q1 | $0 | Hold |
342
| – | – | ﹤0.01% | 4968 |
|
|
2018
Q4 | $0 | Hold |
342
| – | – | ﹤0.01% | 4976 |
|
|
2018
Q3 | $0 | Hold |
342
| – | – | ﹤0.01% | 4871 |
|
|
2018
Q2 | $0 | Sell |
342
-37,241
| -99% | – | ﹤0.01% | 4836 |
|
|
2018
Q1 | $188K | Buy |
37,583
+37,241
| +10,889% | +$186K | ﹤0.01% | 3739 |
|
|
2017
Q4 | $1K | Hold |
342
| – | – | ﹤0.01% | 4625 |
|
|
2017
Q3 | $1K | Hold |
342
| – | – | ﹤0.01% | 4242 |
|
|
2017
Q2 | $1K | Sell |
342
-47,686
| -99% | -$139K | ﹤0.01% | 4274 |
|
|
2017
Q1 | $211K | Sell |
48,028
-5,604
| -10% | -$24.6K | ﹤0.01% | 3468 |
|
|
2016
Q4 | $283K | Sell |
53,632
-1,000
| -2% | -$5.28K | ﹤0.01% | 3520 |
|
|
2016
Q3 | $644K | Buy |
54,632
+1,100
| +2% | +$13K | ﹤0.01% | 2917 |
|
|
2016
Q2 | $546K | Sell |
53,532
-230,150
| -81% | -$2.35M | ﹤0.01% | 2955 |
|
|
2016
Q1 | $3.11M | Buy |
283,682
+57,729
| +26% | +$633K | ﹤0.01% | 2185 |
|
|
2015
Q4 | $2.81M | Buy |
225,953
+89,278
| +65% | +$1.11M | ﹤0.01% | 2223 |
|
|
2015
Q3 | $1.64M | Buy |
136,675
+5,100
| +4% | +$61.2K | ﹤0.01% | 2457 |
|
|
2015
Q2 | $2.26M | Sell |
131,575
-12,950
| -9% | -$223K | ﹤0.01% | 2463 |
|
|
2015
Q1 | $2.83M | Buy |
+144,525
| New | +$2.83M | ﹤0.01% | 2384 |
|